News for Mayne Pharma Group Limited (MYX.AX)

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NMYX.AX - Mayne Pharma Group LtdHalf Year 2025 Mayne Pharma Group Ltd Earnings CallFeb 25, 2025

The major U.S. index futures are currently pointing to a roughly flat open on Friday, with stocks likely to show a lack of direction following the weakness seen in the previous session.

Asian stock markets are trading mostly higher on Friday, despite the broadly negative from Wall Street overnight, as traders seemed cautious and await clarity on US President Donald Trump's trade policies and the outcome of Ukraine peace talks.

Mayne Pharma (ASX: MYX) has received a takeover offer at a price of $7.40 per share from US-based pharmaceutical company Cosette Pharma, valuing the

The ASX200 closed down 0.34% at 8,482 points. Investment manager Franklin Templeton…

Mayne Pharma (ASX: MYX) has reported a forecast revenue of between $210 million and $215m for the first half of the 2025 financial year, reflecting growth

Rising Prevalence of Chronic Pain Conditions and the Geriatric Population Drive Morphine Market Growth...

Revenue: Increased 112% to $388 million.Gross Margin: Expanded to 56.3%, a 24% improvement.Underlying EBITDA: $22.9 million, up $118.2 million from negative $9

The ASX200 broke its winning streak closing slightly down by point zero four of a percent at 8,024 points.

The ASX200 has been down 0.16% at 8,015 points. The market was lead lower by Wall Street as investors await an overnight speech by US Federal Reserve Chair, Jerome Powell.

Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.

The Reserve Bank of Australia Minutes were released on Tuesday morning with traders parsing the documents to get an idea of how likely rate hikes could be.

Mayne Pharma (ASX:MYX) has announced it will pay A$38M – $4.7M covered by insurance – to settle a class action brought in 2021.

Visiongain has published a new report entitled Clinical Trial Supply and Logistics Market for Pharma 2024-2034: Forecasts by Type (CTS Manufacturing, CTS...

The medical health awareness of an individual regarding his sex health has been increasing recently. The main reason behind this is the knowledge given to...

Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was positively...

Feb 25, 2024 / 10:00PM GMTOperator Thank you for standing by, and welcome to the Mayne Pharma Group Limited half year 2024 results call. (Operator Instructions)

The Global Topical Antibiotics Market Size was Valued at USD 5.25 Billion in 2023 and the Worldwide Topical Antibiotics Market Size is Expected to Reach...

Evolving regulations regarding antibiotic use and manufacturing standards impact market dynamics and product offerings....